Skip to content
2000
Volume 24, Issue 4
  • ISSN: 1871-5230
  • E-ISSN: 1875-614X

Abstract

Background

Nonsteroidal anti-inflammatory drugs (NSAIDs) are commonly used to manage pain and inflammation but are associated with gastrointestinal and cardiovascular risks, especially with COX-2 inhibitors. Topical delivery systems offer a safer alternative by minimizing systemic exposure; however, poor solubility and limited skin penetration remain challenges. Enhancing solubility through solid dispersion and incorporating it into a gel formulation may improve permeability and therapeutic effectiveness, addressing the need for safer and more efficient topical NSAID delivery.

Introduction

This investigation aimed to enhance the solubility and dissolution rate of poorly water-soluble etoricoxib through the development of solid dispersions using the kneading method.

Methods

A suitable carrier was selected from a pool of candidates based on polarised microscopy analysis. The influence of a solubilizer on amorphization was evaluated. Solid dispersions of Etoricoxib and its corresponding physical mixtures, incorporating or excluding the solubilizer, were prepared at varying drug-to-carrier ratios. Yield, drug content, saturation solubility, and dissolution profiles of these formulations were determined. Solid-state characterization using Fourier Transform-Infrared (FTIR), X-ray diffraction (XRD), Scanning electron microscopy (SEM), and differential scanning calorimetry (DSC) techniques was conducted.

Results

FTIR spectra indicated the formation of intermolecular hydrogen bonds within the dispersions. XRD, SEM, and DSC analysis confirmed the amorphous transition of crystalline etoricoxib in all the prepared solid dispersions. In comparison to pure etoricoxib and its physical mixes, the produced solid dispersions showed significantly improved dissolution and solubility.

Discussion

Solid dispersion technology effectively enhanced the solubility and dissolution of poorly water-soluble etoricoxib. Polarised microscopy also proved valuable for rapid excipient screening. However, the study was limited by the narrow range of solubilizers tested. While Poloxamer 407 was selected for its availability and untapped potential, broader screening of advanced solubilizers could offer improved outcomes.

Conclusion

The solubility increased from 99.08 to 296.8 μg/ml and the dissolution rose from 69.32% to 98.07%. These findings suggest that the kneading method and Poloxamer successfully produced amorphous solid dispersions of etoricoxib with significantly enhanced solubility and dissolution properties, potentially improving its bioavailability.

© 2025 Bentham Science Publishers
Loading

Article metrics loading...

/content/journals/aiaamc/10.2174/0118715230357451250812171047
2025-09-01
2026-02-28

  • From This Site

    /content/journals/aiaamc/10.2174/0118715230357451250812171047
    dcterms_title,dcterms_subject,pub_keyword
    -contentType:Contributor -contentType:Concept -contentType:Institution
    10
    5
Loading full text...

Full text loading...

References

  1. SaharanV. KukkaV. KatariaM. GeraM. ChoudhuryP. Dissolution enhancement of drugs. Part II: Effect of carriers. Int. J. Health.Res.200923207223
     [Google Scholar]
  2. AinS. AinQ. ParveenS. An overview on various approaches used for solubilization of poorly soluble drugs.Pharm. Res.2009284104
     [Google Scholar]
  3. AmidonG.L. LennernäsH. ShahV.P. CrisonJ.R. A theoretical basis for a biopharmaceutic drug classification: The correlation of in vitro drug product dissolution and in vivo bioavailability.Pharm. Res.199512341342010.1023/a:1016212804288 7617530
     [Google Scholar]
  4. VemulaV.R. LagishettyV. LingalaS. Solubility enhancement techniques.Int. J. Pharm. Sci. Rev. Res.2010514151
     [Google Scholar]
  5. ChiouW.L. RiegelmanS. Pharmaceutical applications of solid dispersion systems.J. Pharm. Sci.19716091281130210.1002/jps.2600600902 4935981
     [Google Scholar]
  6. DhirendraK. LewisS. UdupaN. AtinK. Solid dispersions: A review.Pak. J. Pharm. Sci.2009222234246 19339238
     [Google Scholar]
  7. LeclercqP. MalaiseM.G. Drug of the month. Etoricoxib (Arcoxia).Rev. Med. Liege2004595345349 15270001
     [Google Scholar]
  8. SareenS. JosephL. MathewG. Improvement in solubility of poor water-soluble drugs by solid dispersion.Int. J. Pharm. Investig.201221121710.4103/2230‑973X.96921 23071955
     [Google Scholar]
  9. PatroN.M. SultanaA. TeraoK. NakataD. JoA. UranoA. IshidaY. GorantlaR.N. PanditV. DeviK. RohitS. GrewalB.K. SophiaE.M. SureshA. EkboteV.K. SureshS. Comparison and correlation of in vitro, in vivo and in silico evaluations of alpha, beta and gamma cyclodextrin complexes of curcumin.J. Incl. Phenom. Macrocycl. Chem.2014781-447148310.1007/s10847‑013‑0322‑1
     [Google Scholar]
  10. CaponeML TacconelliS. PatrignaniP. Clinical pharmacology of etoricoxib.Expert Opin. Drug Metab. Toxicol.200512269282
     [Google Scholar]
  11. CochraneD.J. JarvisB. KeatingG.M. Etoricoxib.Drugs200262182637265110.2165/00003495‑200262180‑00006 12466002
     [Google Scholar]
  12. PatelD.M. PatelM.M. Optimization of fast dissolving etoricoxib tablets prepared by sublimation technique.Indian J. Pharm. Sci.2008701717610.4103/0250‑474X.40335 20390084
     [Google Scholar]
  13. PatelH. SuhagiaB. ShahS. RathodI. ParmarV. Preparation and characterization of etoricoxib-β-cyclodextrin complexes prepared by the kneading method.Acta. Pharm.200757335135910.2478/v10007‑007‑0028‑2 17878114
     [Google Scholar]
  14. AlKhalidiM.M. Enhancement of aqueous solubility and dissolution rate of etoricoxib by solid dispersion technique.Iraqi J. Pharm Sci.2020291768710.31351/vol29iss1pp76‑87
     [Google Scholar]
  15. GuptaP. KakumanuV.K. BansalA.K. Stability and solubility of celecoxib-PVP amorphous dispersions: A molecular perspective.Pharm. Res.200421101762176910.1023/B:PHAM.0000045226.42859.b8 15553220
     [Google Scholar]
  16. NayakA.K. PanigrahiP.P. Solubility enhancement of etoricoxib by cosolvency approach.ISRN Physical Chemistry201220121510.5402/2012/820653
     [Google Scholar]
  17. BrooksP. KublerP. Etoricoxib for arthritis and pain management.Ther. Clin. Risk Manag.2006214557 18360581
     [Google Scholar]
  18. HuangW.N. TsoT.K. Etoricoxib improves osteoarthritis pain relief, joint function, and quality of life in the extreme elderly.Bosn. J. Basic Med. Sci.2018181879410.17305/bjbms.2017.2214 28954205
     [Google Scholar]
  19. BirbaraC.A. PuopoloA.D. MunozD.R. SheldonE.A. MangioneA. BohidarN.R. GebaG.P. Treatment of chronic low back pain with etoricoxib, a new cyclo-oxygenase-2 selective inhibitor: improvement in pain and disability—A randomized, placebo-controlled, 3-month trial.J. Pain20034630731510.1016/S1526‑5900(03)00633‑3 14622687
     [Google Scholar]
  20. MuralidharS. RaoS.D. RameshR. NarayanaT.V. Studies to enhance dissolution properties of etoricoxib.Int. J. Pharm. Res. Dev.201124
     [Google Scholar]
  21. SuhagiaB.N. PatelH.M. ShahS.A. RathodI. ParmarV.K. Preparation and characterization of etoricoxib-polyethylene glycol 4000 plus polyvinylpyrrolidone K30 solid dispersions.Acta Pharm.2006563285298 19831278
     [Google Scholar]
  22. KarekarP. VyasV. ShahM. SanchetiP. PoreY. Physicochemical investigation of the solid dispersion systems of etoricoxib with poloxamer 188.Pharm. Dev. Technol.200914437337910.1080/10837450802683974 19552551
     [Google Scholar]
  23. DhaS.M. RaoG.D. ReddyB.M. NarayanaT.V. Fast dissolving etoricoxib tablets containing solid dispersion of etoricoxib.Int. J. Drug Formul Res.201013309323
     [Google Scholar]
  24. DasA. NayakA.K. MohantyB. PandaS. Solubility and dissolution enhancement of etoricoxib by solid dispersion technique using sugar carriers.ISRN Pharm.201120111810.5402/2011/819765 22389861
     [Google Scholar]
  25. ChowdaryK.P.R. RaoK.S.P. MadhuriD. A factorial study on the effects of cyclodextrins, poloxamer 407 and PVP on the solubility and dissolution rate of etoricoxib.Int. J. Chem. Sci.20119677686
     [Google Scholar]
  26. SapkalS.B. AdhaoV.S. ThengeR.R. DarakheR.A. ShindeS.A. ShrikhandeV.N. Formulation and characterization of solid dispersions of etoricoxib using natural polymers.Turk J. Pharm. Sci.202017171910.4274/tjps.galenos.2018.04880 32454755
     [Google Scholar]
  27. Polarised light microscopy.2024Available from : https://myscope.training/LFM_Polarised_light_microscopy
  28. LangeN. Caffeine crystals in polarized light under the microscope 100x.2024Available from : https://www.123rf.com/photo_154981047_caffeine-crystals-in-polarized-light-under-the-microscope-100x.html
  29. Role of excipients in amorphous solid dispersions.2018Available from : https://www.youtube.com/watch?v=vXw6nfnjbPk
  30. EnoseA.A. DasanP.K. SivaramakrishnanH. ShahS.M. Formulation and characterization of solid dispersion prepared by hot melt mixing: A fast screening approach for polymer selection.J. Pharm.2014201411310.1155/2014/105382 26556187
     [Google Scholar]
  31. AnupamaK. NeenaB. Formulation and evaluation of mouth dissolving tablets of oxcarbazepine.Int. J. Pharm. Pharm. Sci.200911223
     [Google Scholar]
  32. ChavanR.B. LodagekarA. YadavB. ShastriN.R. Amorphous solid dispersion of nisoldipine by solvent evaporation technique: Preparation, characterization, in vitro, in vivo evaluation, and scale up feasibility study.Drug Deliv. Transl. Res.202010490391810.1007/s13346‑020‑00775‑8 32378174
     [Google Scholar]
  33. RajA.L. KumarY.S. Preparation and evaluation of solid dispersion of nebivolol using solvent evaporation method.Int. J. Pharm. Sci. Drug Res.201810432232810.25004/IJPSDR.2018.100418
     [Google Scholar]
  34. SharmaA. JainC.P. Preparation and characterization of solid dispersions of carvedilol with PVP K30.Res. Pharm. Sci.2010514956 21589768
     [Google Scholar]
  35. OkoyeE. EzenwaC. AburimeO. EkweoguA. Comparative evaluation of coprecipitation, solvent evaporation, and kneading as techniques to improve solubility and dissolution profiles of a BCS class IV drug.Egypt Pharm. J.201716212110.4103/epj.epj_7_17
     [Google Scholar]
  36. PutchakayalaS.B. Amorphous solid dispersion — An ideal formulation approach to improve developability.Available from2024Available from : https://www.youtube.com/watch?v=oUZXcH77I-I
  37. KaliaA. PoddarM. Solid dispersions: An approach towards enhancing dissolution rate.Int. J. Pharm. Pharm. Sci.20113919
     [Google Scholar]
  38. BabootaS. DhaliwalM. KohliK. Physicochemical characterization, in vitro dissolution behavior, and pharmacodynamic studies of rofecoxib-cyclodextrin inclusion compounds. Preparation and properties of rofecoxib hydroxypropyl β-cyclodextrin inclusion complex: A technical note.AAPS PharmSciTech200561E83E9010.1208/pt060114 16353967
     [Google Scholar]
  39. SapkalS. Natural polymers: Best carriers for improving bioavailability of poorly water.Marmara Pharm. J.2013217657210.12991/201317375
     [Google Scholar]
  40. Abd-El BaryA. Olmesartan medoxomil surface solid dispersion-based orodispersible tablets: Formulation and in vitro characterization.J. Drug Deliv. Sci. Technol.201424666567210.1016/S1773‑2247(14)50134‑7
     [Google Scholar]
  41. de França Almeida MoreiraC.D.L. de Oliveira PinheiroJ.G. da Silva-JúniorW.F. BarbosaE.G. LavraZ.M.M. PereiraE.W.M. ResendeM.M. de AzevedoE.P. Quintans-JúniorL.J. de Souza AraújoA.A. de Souza Siqueira QuintansJ. de LimaÁ.A.N. Amorphous solid dispersions of hecogenin acetate using different polymers for enhancement of solubility and improvement of anti-hyperalgesic effect in neuropathic pain model in mice.Biomed. Pharmacother.20189787087910.1016/j.biopha.2017.10.161 29136763
     [Google Scholar]
  42. KumarA. GlobaleP. SahooS.K. Review on solubility enhancement techniques for hydrophobic drugs.Int. J. Pharm. Sci.201133
     [Google Scholar]
  43. PatelV. PatelR. ShahH. PurohitS. PawarM. PathanA. Solubility enhancement of azithromycin by solid dispersion technique using mannitol and β-cyclodextrin. Acta.Sci. Pharma. Sci.202154485410.31080/ASPS.2021.05.0701
     [Google Scholar]
  44. LatschS. SelzerT. FinkL. KreuterJ. Determination of the physical state of norethindrone acetate containing transdermal drug delivery systems by isothermal microcalorimetry, X-ray diffraction, and optical microscopy.Eur. J. Pharm. Biopharm.200457238339510.1016/S0939‑6411(03)00158‑9 15019000
     [Google Scholar]
  45. UsuiF. MaedaK. KusaiA. NishimuraK. KeijiYamamoto, Inhibitory effects of water-soluble polymers on precipitation of RS-8359.Int. J. Pharm.19971541596610.1016/S0378‑5173(97)00129‑4
     [Google Scholar]
  46. SuzukiH. SunadaH. Influence of water-soluble polymers on the dissolution of nifedipine solid dispersions with combined carriers.Chem. Pharm. Bull199846348248710.1248/cpb.46.482 9549890
     [Google Scholar]
  47. OhM.J. The dissolution property of raloxifene HCl solid dispersion using hydroxypropyl methylcellulose.Macromol. Res.201220883584110.1007/s13233‑012‑0127‑x
     [Google Scholar]
  48. GaoP. MorozowichW. Development of supersaturatable self-emulsifying drug delivery system formulations for improving the oral absorption of poorly soluble drugs.Expert Opin. Drug Deliv.2006319711010.1517/17425247.3.1.97 16370943
     [Google Scholar]
  49. YamashitaK. NakateT. OkimotoK. OhikeA. TokunagaY. IbukiR. HigakiK. KimuraT. Establishment of new preparation method for solid dispersion formulation of tacrolimus.Int. J. Pharm.20032671-2799110.1016/j.ijpharm.2003.07.010 14602386
     [Google Scholar]
  50. FanN. HeZ. MaP. WangX. LiC. SunJ. SunY. LiJ. Impact of HPMC on inhibiting crystallization and improving permeability of curcumin amorphous solid dispersions.Carbohydr. Polym.201818154355010.1016/j.carbpol.2017.12.004 29254005
     [Google Scholar]
  51. HadgraftJ. LaneM.E. Drug crystallization - Implications for topical and transdermal delivery.Expert Opin. Drug Deliv.201613681783010.1517/17425247.2016.1140146 26766744
     [Google Scholar]
  52. Al-ShboulT. SagalaF. NassarN.N. Role of surfactants, polymers, nanoparticles, and its combination in inhibition of wax deposition and precipitation: A review.Adv. Colloid Interface Sci.2023315102904410.1016/j.cis.2023.102904 37084545
     [Google Scholar]
  53. EerdenbrughB. TaylorL.S. Small scale screening to determine the ability of different polymers to inhibit drug crystallization upon rapid solvent evaporation.Mol. Pharm.201074132810.1021/mp1001153 20536263
     [Google Scholar]
  54. FakhreevaA.V. NosovV.V. VoloshinA.I. DokichevV.A. Polysaccharides as effective and environmentally friendly inhibitors of scale deposition from aqueous solutions in technological processes.Polymers20231561478810.3390/polym15061478 36987258
     [Google Scholar]
  55. WongW.F. KuanP.A. SethiG. Recent advancement of medical patch for transdermal drug delivery.Medicina2023594778810.3390/medicina59040778 37109736
     [Google Scholar]
  56. TahirM.A. AliM.E. LamprechtA. Nanoparticle formulations as recrystallization inhibitors in transdermal patches.Int. J. Pharm.202057511888610.1016/j.ijpharm.2019.118886 31790804
     [Google Scholar]
  57. MackellarA.J. BucktonG. NewtonJ.M. OrrC.A. The controlled crystallisation of a model powder: 2. Investigation into the mechanism of action of poloxamers in changing crystal properties.Int. J. Pharm.19941121798510.1016/0378‑5173(94)90263‑1
     [Google Scholar]
  58. OleksyM. DynarowiczK. AebisherD. Advances in biodegradable polymers and biomaterials for medical applications-A review.Molecules20232817621310.3390/molecules28176213 37687042
     [Google Scholar]
  59. WangY. ChenG. ZhangH. ZhaoC. SunL. ZhaoY. Emerging functional biomaterials as medical patches.ACS Nano20211545977600710.1021/acsnano.0c10724 33856205
     [Google Scholar]
  60. OverhoffK.A. McConvilleJ.T. YangW. JohnstonK.P. PetersJ.I. WilliamsR.O. Effect of stabilizer on the maximum degree and extent of supersaturation and oral absorption of tacrolimus made by ultra-rapid freezing.Pharm. Res.200825116717510.1007/s11095‑007‑9417‑y 17968635
     [Google Scholar]
  61. NandiyantoA.B.D. RagadhitaR. FiandiniM. Interpretation of fourier transform infrared spectra (FTIR): A practical approach in the polymer/plastic thermal decomposition.Indones J. Sci. Technol20228111312610.17509/ijost.v8i1.53297
     [Google Scholar]
  62. RosiakN. TykarskaE. Cielecka-PiontekJ. The study of amorphous kaempferol dispersions involving FTIR Spectroscopy.Int. J. Mol. Sci.202324241715510.3390/ijms242417155 38138984
     [Google Scholar]
  63. VeigaM.D. DíazP.J. AhsanF. Interactions of griseofulvin with cyclodextrins in solid binary systems.J. Pharm. Sci.199887789190010.1021/js970233x 9649360
     [Google Scholar]
  64. DumortierG. GrossiordJ.L. AgnelyF. ChaumeilJ.C. A review of poloxamer 407 pharmaceutical and pharmacological characteristics.Pharm. Res.200623122709272810.1007/s11095‑006‑9104‑4 17096184
     [Google Scholar]
  65. VeigaM.D. AhsanF. Study of tolbutamide-hydroxypropyl-gamma-cyclodextrin interaction in solution and solid state.Chem. Pharm. Bull200048679379710.1248/cpb.48.793 10866138
     [Google Scholar]
  66. Appa RaoB. ShivalingamM.R. Kishore ReddyY.V. RaoS. RajeshK. SunithaN. Formulation and evaluation of aceclofenac solid dispersions for dissolution rate enhancement.Int. J. Pharm. Sci. Drug Res.201022146150
     [Google Scholar]
  67. AhujaN. KatareO.P. SinghB. Studies on dissolution enhancement and mathematical modeling of drug release of a poorly water-soluble drug using water-soluble carriers.Eur. J. Pharm. Biopharm.2007651263810.1016/j.ejpb.2006.07.007 16962750
     [Google Scholar]
  68. AbdelkaderH. AbdallaO.Y. SalemH. Formulation of controlled-release baclofen matrix tablets: Influence of some hydrophilic polymers on the release rate and in vitro evaluation.AAPS PharmSciTech200784E10010.1208/pt0804100 18181521
     [Google Scholar]
  69. RoniM. Effects of poloxamer and HPMC on the dissolution of clonazepam-polyethylene glycol solid dispersions and tablets.Indian J. Pharm. Educ. Res.2011452139144
     [Google Scholar]
/content/journals/aiaamc/10.2174/0118715230357451250812171047
Loading
Preparation and Evaluation of Amorphous Solid Dispersion of Etoricoxib, Employing A Fast Approach for Polymer Selection
Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry 24, 242 (2025); https://doi.org/10.2174/0118715230357451250812171047
/content/journals/aiaamc/10.2174/0118715230357451250812171047
/content/journals/aiaamc/10.2174/0118715230357451250812171047
Loading

Data & Media loading...


  • Article Type:     Research Article
Keyword(s): amorphization; dissolution rate; etoricoxib; kneading method; Solid dispersions; solubility

Most Cited Most Cited RSS feed

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test